Adolfo Garcia-Sastre

Adolfo Garcia-Sastre

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2020 in Nature
Verified
Journal Article
Closed access
PDF file
DGDavid E. Gordon
David E. Gordon
GJGwendolyn M. Jang
Gwendolyn M. Jang
MBMehdi Bouhaddou
Mehdi Bouhaddou
JXJiewei Xu
Jiewei Xu
KOKirsten Obernier
Kirsten Obernier
NKNevan J. Krogan
Nevan J. Krogan

1 April 2013 in Immunity
Verified
Journal Article
Closed access
DHDaigo Hashimoto
Daigo Hashimoto
ACAndrew Chow
Andrew Chow
CNClara Noizat
Clara Noizat
PTPearline Teo
Pearline Teo
MBMary Beth Beasley
Mary Beth Beasley
MMMiriam Merad
Miriam Merad

23 October 2020 in Science
Verified
Journal Article
Open access
PDF file
QZQian Zhang
Qian Zhang
PBPaul Bastard
Paul Bastard
ZLZhiyong Liu
Zhiyong Liu
JPJérémie Le Pen
Jérémie Le Pen
MMMarcela Moncada-Velez
Marcela Moncada-Velez
JCJean-Laurent Casanova
Jean-Laurent Casanova
The genetics underlying severe COVID-19: The immune system is complex and involves many genes, including those that encode cytokines known as interferons (IFNs). Individuals that lack specific IFNs can be more susceptible to infectious diseases. Furthermore, the autoantibody system dampens IFN response to prevent damage from pathogen-induced inflammation. Two studies now examine the likelihood that genetics affects the risk of severe coronavirus disease 2019 (COVID-19) through components of this system (see the Perspective by Beck and Aksentijevich). Q. Zhang et al. used a candidate gene approach and identified patients with severe COVID-19 who have mutations in genes involved in the regulation of type I and III IFN immunity. They found enrichment of these genes in patients and conclude that genetics may determine the clinical course of the infection. Bastard et al. identified individuals with high titers of neutralizing autoantibodies against type I IFN-α2 and IFN-ω in about 10% of patients with severe COVID-19 pneumonia. These autoantibodies were not found either in infected people who were asymptomatic or had milder phenotype or in healthy individuals. Together, these studies identify a means by which individuals at highest risk of life-threatening COVID-19 can be identified. Science , this issue p. eabd4570 , p. eabd4585 ; see also p. 404

12 May 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
FAFatima Amanat
Fatima Amanat
DSDaniel Stadlbauer
Daniel Stadlbauer
SSShirin Strohmeier
Shirin Strohmeier
TNThi Hoang Oanh Nguyen
Thi Hoang Oanh Nguyen
VCVeronika Chromikova
Veronika Chromikova
Florian KrammerFlorian Krammer
Florian Krammer

28 June 2018 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
FKFlorian Krammer
Florian Krammer
GSGavin J. D. Smith
Gavin J. D. Smith
RFRon A. M. Fouchier
Ron A. M. Fouchier
MPMalik Peiris
Malik Peiris
KKKatherine Kedzierska
Katherine Kedzierska
AGAdolfo Garcia-Sastre
Adolfo Garcia-Sastre

7 October 2005 in Science
Verified
Journal Article
Closed access
PDF file
TTTerrence M. Tumpey
Terrence M. Tumpey
CBChristopher F Basler
Christopher F Basler
PAPatricia V. Aguilar
Patricia V. Aguilar
HZHui Zeng
Hui Zeng
ASAlicia Solórzano
Alicia Solórzano
AGAdolfo Garcia-Sastre
Adolfo Garcia-Sastre
The pandemic influenza virus of 1918–1919 killed an estimated 20 to 50 million people worldwide. With the recent availability of the complete 1918 influenza virus coding sequence, we used reverse genetics to generate an influenza virus bearing all eight gene segments of the pandemic virus to study the properties associated with its extraordinary virulence. In stark contrast to contemporary human influenza H1N1 viruses, the 1918 pandemic virus had the ability to replicate in the absence of trypsin, caused death in mice and embryonated chicken eggs, and displayed a high-growth phenotype in human bronchial epithelial cells. Moreover, the coordinated expression of the 1918 virus genes most certainly confers the unique high-virulence phenotype observed with this pandemic virus.